%0 Journal Article
%B Circulation
%D 2018
%G eng
%N 4
%P 323-334
%R 10.1161/CIRCULATIONAHA.117.032038
%T Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
%V 137
%1 https://www.ncbi.nlm.nih.gov/pubmed/29133604?dopt=Abstract